11.08.20|Golan HazaniPicodya develops an in vitro diagnostics (IVD) platform named B-Matrix and is valued at between $80 and $100 million
06.11.17|Keren Tsuriel HarariWith stakes in three companies, one of them sold to a Mexican piping company for $1.5 billion, Israel’s Kibbutz Hatzerim runs a varied investment portfolio, reflecting a five-year strategic plan